Skip to search formSkip to main contentSkip to account menu

Biaxin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
6739 Background: Levels of serum sIL-2R represents the total amount of activated T lymphocytes in tumor infiltrating lymphocytes… 
2004
2004
OBJECTIVE To report the first comprehensive analysis of clarithromycin (CLA) and 14-(R)-hydroxyclarithromcin (14R) bioequivalence… 
2003
2003
Many antibiotic monographs cite the induction of vaginal infections as a possible side effect. Invariably, this is believed to be… 
Review
2003
Review
2003
Clarithromycin (Biaxin®) extended-release tablets, an advanced generation macrolide, were recently introduced into the USA for… 
2000
2000
OBJECTIVE To assess the bioequivalence of two tablet formulations of clarithromycin (Clamicin 500 mg from Medley Indlistria… 
1998
1998
Factors influencing the pharmacokinetics of clarithromycin in gastric mucus are poorly defined. 
1995
1995
In 1995, the Food and Drug Administration (FDA) extended the label use of Biaxin (clarithromycin) to include prophylaxis…